MOSY Stock Chart & Historical Trading Data $MOSY Updated:

New Post Public Reply Private Reply Replies (0) Message Board
stockcharts
52
MOSY Stock Chart & Historical Trading Data $MOSY Updated: 01-26-2017
Last Trade: 1/25/2017
Last 0.350   
Open 0.260
Previous Close 0.350
Day High / Low 0.370 / 0.250
Year High / Low 0.990 / 0.180
Volume 10,199,184
Projected Volume 10199184 (569%)
# of Trades / Projected 8,591 / 8,591
Dividend / Yield - / 0.00%
Abnormal Activity ABNORMAL DAY UP
Abnormal Volume ABNORMAL VOLUME
Gap NONE
Candle BULLISH
Volatility Today HIGH
Volatility Yesterday MEDIUM
Price Relativity
From 40 Day High 76%
From 80 Day High 45%
From 150 Day High 44%
From 40 Day Low 184%
From 80 Day Low 184%
From 150 Day Low 184%
Pivot Analysis
Price Pivot $ 0.320
Day Resistance 1 $ 0.400
Day Support 1 $ 0.280
Day Resistance 2 $ 0.440
Day Support 2 $ 0.200
Consolidations
Short Term NO
Medium Term NO
Long Term NO
Volume Indicators
20 Day Avg Vol 1,791,803
Today / 20 Day Avg Vol ABOVE
150 Day Avg Vol 321,079
Today / 150 Day Avg Vol ABOVE
Abnormal Volume ABNORMAL VOLUME
William Volume Accumulation bullish
Volume Price Trend bullish
Momentum Indicators
10 Day Trend bullish
40 Day Trend bearish
100 Day Trend bearish
Stochastics bearish
RSI neutral
MACD bearish
Moving Average Indictors
15 Day Trend bullish
45 Day Trend bearish
100 Day Trend bearish
Mid Term Moving Average Crossover NONE
Long Term Moving Average Crossover NONE
Volatility Indicators
Abnormal Activity Today? ABNORMAL DAY UP
Volatility Index Today HIGH
Volatility Index Yesterday MEDIUM
10 Day Volatility INCREASING
20 Day Volatility INCREASING
40 Day Volatility INCREASING

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Revolutionary AI Improves Immunology and Cancer Research Efficiency

Updated Category News Views 107

Transforming Research with AI Technology BD (Becton, Dickinson and Company) (NYSE: BDX) has recently launched an innovative tool that is set to transform the landscape of immunology and cancer research. The introduction of the BD® Research Cloud 7.0, featuring the BD Horizon™ Panel Maker, is redefining how scientists approach experimental design in these critical...

Continue Reading
Strategic Collaboration of IONETIX and AlfaRim Medical Unveiled

Updated Category News Views 347

Strategic Partnership Between IONETIX and AlfaRim Medical In a significant move within the medical isotope industry, IONETIX Corporation has announced a strategic partnership with AlfaRim Medical B.V. This collaboration sets the stage for accelerating the commercial production of Actinium-225, a crucial isotope used in targeted alpha therapies for various cancers. As...

Continue Reading
Endeavour Silver's Terronera Project Achieves Major Milestones

Updated Category News Views 62

Endeavour Silver's Terronera Project Update: Key Developments Endeavour Silver Corp. (NYSE: EXK; TSX: EDR) has unveiled a significant third-quarter construction progress report for its Terronera Project located in Mexico. The company takes pride in its remarkable strides toward achieving full operational readiness. Progress Overview The Terronera Project has progressed...

Continue Reading
Healthcare Sector Faces Major Cybersecurity Challenges Amid Breaches

Updated Category News Views 224

Significant Rise in Healthcare Data Breaches In the healthcare industry, data breaches hit a dramatic peak, leading to an alarming tally of over 276 million records compromised. This stunning figure represents a staggering 64.1% increase from prior years, illustrating profound vulnerabilities in the protection of sensitive patient information. As such, the harsh reality...

Continue Reading
Tempus AI Investors Prepare for Class Action Opportunity

Updated Category News Views 131

Understanding the Tempus AI Class Action Lawsuit Investors in Tempus AI, Inc. (NASDAQ: TEM) may find themselves in a position to lead a class action lawsuit following substantial financial losses. This legal opportunity arises from significant allegations against the company, which purports to be advancing precision medicine through artificial intelligence. Who Can...

Continue Reading